Tivic Health Systems Inc (TIVC)
1.05
+0.01
(+0.96%)
USD |
NASDAQ |
May 01, 16:00
1.08
+0.03
(+2.86%)
After-Hours: 20:00
Tivic Health Systems Research and Development Expense (Quarterly): 0.36M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.36M |
| September 30, 2023 | 0.337M |
| June 30, 2023 | 0.468M |
| March 31, 2023 | 0.49M |
| December 31, 2022 | 0.435M |
| September 30, 2022 | 0.399M |
| June 30, 2022 | 0.497M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.401M |
| December 31, 2021 | 0.313M |
| September 30, 2021 | 0.175M |
| June 30, 2021 | 0.192M |
| March 31, 2021 | 0.198M |
| December 31, 2020 | 0.093M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.093M
Minimum
Dec 2020
0.497M
Maximum
Jun 2022
0.3352M
Average
0.36M
Median
Dec 2023
Research and Development Expense (Quarterly) Benchmarks
| Spectral AI Inc | -- |
| Perspective Therapeutics Inc | 6.08M |
| Xtant Medical Holdings Inc | 0.492M |
| Asensus Surgical Inc | 8.614M |
| Catheter Precision Inc | -0.011M |